Centers that interpret mammograms but do not perform the actual imaging need not be accredited under the Mammography Quality Standard Act of 1992, the FDA has ruled.Under a draft guidance recently issued by the agency, such partial providers are covered
Centers that interpret mammograms but do not perform the actual imaging need not be accredited under the Mammography Quality Standard Act of 1992, the FDA has ruled.
Under a draft guidance recently issued by the agency, such partial providers are covered under the certification of the system that hires them for interpretation.
Facilities that interpret mammograms may apply for certification if they wish. However, they would have to pay certification fees and could incur additional legal responsibilities.
The additional responsibilities would include providing assurance that interpreting facilities and those that produce and process the mammograms meet the MQSAs stringent quality control standards. Payment of an annual MQSA inspection fee would also be required.
The provider of some component of the system that performs mammography must take the lead in obtaining an MQSA certificate, the draft said. The FDA expects that in most cases the owner of an x-ray unit or units will apply for accreditation and receive a certificate. If one or more of the facilities for which you interpret mammograms is applying for accreditation and certification, your responsibility will be to provide them with information documenting that the physicians in your group meet MQSA requirements for interpreting physicians.
Several other issues were also addressed in the lengthy document. The draft indicated that for accreditation purposes, certification by the American Registry of Radiologic Technologists is sufficient proof of training in breast anatomy and physiology, positioning and compression, quality control and assurance techniques, and the imaging of patients with breast implants.
A masters degree or higher in physics (for physicists) is adequate documentation that the required number of semester hours has been achieved, the FDA said.
This exemption is designed to loosen requirements on physicians who interpret exams only, freeing them from many of the application processes and requirements that (are involved in) MQSA certification, said Dr. Douglas P. Beall, director of interventional services at Sheppard Air Force Base in Wichita Falls, TX.
Beall is something of an expert on mammography quality. He spent eight weeks last year working to improve the radiologic techniques at a medical center in Tanzania.
This loosens unnecessary restrictions and will, we hope, encourage more widespread interpretation of exams by those radiologists qualified to do it under the MQSA standards for interpretation, Beall said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.